Fatemeh Nouri Emamzaden

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

NCTR

Graduate Student Researcher

1 h-index 3 pubs 1 cited

Research Areas

OverviewAI-generated summary

Fatemeh Nouri Emamzaden's research focuses on investigating the anti-cancer effects of compounds like vorinostat, an HDAC inhibitor, on various cancer cell models. Her work includes studying the expression of specific gene profiles in organoids derived from pancreatic cancer tumors, particularly those from African American patients. Emamzaden also investigates the role of GSK3β in triple-negative breast cancer and the impact of vorinostat on these cells. Her scholarship metrics include an h-index of 1 with 3 total publications and 1 total citation. She has collaborated on multiple publications with researchers at the National Center for Toxicological Research, including George Hammons, Beverly Word, and Beverly Lyn-Cook.

Metrics

h-index: 1
Publications: 3
Citations: 1

Selected Publications

Abstract 4253: High expression of specific gene profiles in organoids from African American pancreatic cancer tumors (2024)

Cancer Research DOI OpenAlex
Abstract 6251: High expression level of GSK3β in basal triple negative breast cancer: Effects of the HDAC inhibitor, vorinostat (2023)

Cancer Research DOI OpenAlex
Abstract 1631: Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells (2022)

Cancer Research 1 citation DOI OpenAlex